46 / 63
46
-
Overall, the median frequency of pCR
from
15 trials
of
neoadjuvant chemotherapy
is 4%
- 492 patients with stage IB-II NSCLC treated with
neoadyuvant chemotherapy:
- 8% of those resected had a pCR
- Patients with pCR, the five-year survival significantly
improved (80% vs 56% without pCR, p>0.01)
(Mouillet G, et al. JTO 2012)
Looking for new subrogate